Monday, July 20, 2015
Stanford Spinout SiteOne Therapeutics Gets Funding
SiteOne Therapeutics, a Stanford University spinout developing treatments for acute and chronic pain, said last week that it has received a round of funding. Size of the funding for the company was not announced. SiteOne Therapeutics said the funding was led by Next Frontier Capital, and also included 2M Companies Inc., Sears Capital Management, Biobrit LLC, Mission Bay Capital and Z Investments. SiteOne Therapeutics is based in Bozeman, Montana. SiteOne says it has and exclusive license from Stanford University for its technology. More information »